Skip to main content
Clinical Trials/CTRI/2024/07/071655
CTRI/2024/07/071655Not yet recruitingPhase 3

Evaluation of the comparative efficacy of Vidarikand vati (Pueraria tuberosa DC) vs. Ashwagandha vati (Withania somnifera Linn) in Karshya (underweight): Randomized controlled trial. - A randomised controlled experiment was conducted to assess the comparative effectiveness of Vidarikand vati and Ashwagandha vati in treating karshya (underweight).

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Patients willing to Participate in the Study and give written informed
  • 2 Age between 20 to 30 years of either sex
  • 3 Patients having BMI in between 14 to 19 kilogram meter squire
  • 4 Patients having Hemoglobin more then 8 gram per deciliter

Exclusion Criteria

  • Patients with acute complications like Cirrhosis of liver Pancreatitis
  • Tuberculosis Diabetes mellitus Diabetes insipidus Hyperthyroidism
  • Severe Anaemia Hb less than 8gm/dl Other systemic diseases like
  • CKD CHD and other Immuno Compromised disease like HIV
  • Rheumatoid arthritis etc

Investigators

Sponsor
Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha

Similar Trials